Vimarsana
Biggest News Aggregation in the World

Page 8 - Johan Dalsgaard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johan Dalsgaard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johan Dalsgaard Today - Breaking & Trending Today

Vicore's C21 reduces long-term lung injury after COVID-19 in the ATTRACT Phase 2 extension study - Vimarsana News

Vicore's C21 reduces long-term lung injury after COVID-19 in the ATTRACT Phase 2 extension study

Published: November 2, 2021

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders...

Source: prnewswire.com
Related Topics:
United KingdomVastra Gotalands LanCzech RepublicSouth AfricaElin RosendahlVicore PharmaCarl Johan DalsgaardVicore Pharma HoldingJohan DalsgaardPharma HoldingVicore Pharma Holding AbHealth Care Amp Hospitals Medical Pharmaceuticals Olls And Research
Lancet's EClinicalMedicine publishes phase 2 data on C21 in COVID-19 - Vimarsana News

Lancet's EClinicalMedicine publishes phase 2 data on C21 in COVID-19

Published: October 25, 2021

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders,...

Source: prnewswire.com
Related Topics:
United KingdomJoanna PorterCarl Johan DalsgaardUniversity College London HospitalsVicore Pharma HoldingFoundation TrustChief InvestigatorProfessor Joanna PorterJohan DalsgaardPharma HoldingVicore Pharma Holding Ab
Vicore To Host Key Opinion Leader Webinar On C21 For The Treatment of Idiopathic Pulmonary Fibrosis (IPF) - Vimarsana News

Vicore To Host Key Opinion Leader Webinar On C21 For The Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Published: September 22, 2021

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomCity OfVastra Gotalands LanToby MaherRohit BattaCarl Johan DalsgaardJoanna PorterInternational Advisory Board For Lancet Respiratory MedicineUniversity College LondonLung InstituteClinical Research FacilityFibrosis Research GroupUniversity Of Southern CaliforniaNational Interstitial Lung DiseaseNational HeartBritish Lung FoundationResearch At Royal Brompton HospitalKeck School Of MedicinePrnewswire Vicore Pharma HoldingMatters CharityImperial CollegeNational Institute For Health ResearchVicore Pharma HoldingProfessor Toby Maher
Vicore Pharma Holding AB: Vicore obtains SARS coronavirus patent for C21 in the USA - Vimarsana News

Vicore Pharma Holding AB: Vicore obtains SARS coronavirus patent for C21 in the USA

Published: September 22, 2021

GOTHENBURG, Sweden, Sept. 22, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders

Source: finanznachrichten.de
Related Topics:
United StatesVastra Gotalands LanCarl Johan DalsgaardTrademark OfficePrnewswire Vicore Pharma HoldingSevere Acute Respiratory SyndromeVicore PharmaJohan RaudJohan Dalsgaardஒன்றுபட்டது மாநிலங்களில்முத்திரை அலுவலகம்கடுமையானது எடுப்போசை சுவாச நோய்க்குறிஜோஹன் ரௌட்
Vicore obtains SARS coronavirus patent for C21 in the USA - Vimarsana News

Vicore obtains SARS coronavirus patent for C21 in the USA

Published: September 22, 2021

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders,...

Source: prnewswire.com
Related Topics:
United StatesVastra Gotalands LanCarl Johan DalsgaardTrademark OfficePrnewswire Vicore Pharma HoldingVicore Pharma HoldingSevere Acute Respiratory SyndromeVicore PharmaJohan RaudJohan DalsgaardPharma Holdingஒன்றுபட்டது மாநிலங்களில்முத்திரை அலுவலகம்கடுமையானது எடுப்போசை சுவாச நோய்க்குறிஜோஹன் ரௌட்பார்மா வைத்திருத்தல்Vicore Pharma Holding AbHealth Care Amp Hospitals Medical Pharmaceuticals Pharmaceuticals